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Abstract
Background: Quorum sensing is a cell-to-cell communication system in bacteria that controls the production of  virulence fac-
tors. Serratia marcescens is a causative agent of  hospital-acquired infections that shows high resistance to antibiotics. This makes 
the treatment of  these infections difficult. Quorum sensing regulates the production of  virulence factors of  S. marcescens such as 
prodigiosin, protease, swimming and swarming motilities and formation of  biofilms. Inhibition of  quorum sensing may be an 
alternative to antibiotic treatment to avoid emergence of  resistance.
Objectives: Testing the ability of  glyceryl trinitrate to inhibit quorum sensing and virulence factors of  Serratia marcescens.
Methods: The inhibiting activities of  sub-inhibitory concentration of  glyceryl trinitrate against the quorum-sensing regulated 
violacein pigment in Chromobacterium violaceum CV026 was performed to evaluate the anti-quorum sensing effect of  glyceryl 
trinitrate. The anti-virulence activity was assessed against prodigiosin, protease, biofilm formation in addition to swimming and 
swarming motilities.
Results:  Glyceryl trinitrate at at a concentration of  0.25 mg/ml produced significant inhibitory effects against violacein (67.01%), 
prodigiosin (82.67%), protease, swimming (36.72%) and swarming (79.31%) motilities and biofilm formation (87.83%).
Conclusion: Glyceryl trinitrate is a quorum sensing and virulence inhibitor that may be useful in treatment of  nosocomial in-
fections caused by Serratia marcescens.
Keywords: Serratia marcescens, quorum sensing, virulence, glyceryl trinitrate.
DOI: https://dx.doi.org/10.4314/ahs.v18i1.2
Cite as: Abbas HA, Elsherbini AM. Silencing the noscomial pathogen Serratia marscescens by glyceryl trinitrate. Afri Health Sci 2018;18(1): 
1-10. https://dx.doi.org/10.4314/ahs.v18i1.2
Introduction
Serratia marcescens is a nosocomial pathogen that can lead 
to many nosocomial infections such as those affecting 
urinary tract, respiratory tract in addition to wound in-
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fections. It has an arsenal of  virulence factors that aid 
in escape from the immune system and causing these 
infections such as prodigiosin, proteases, biofilm and its 
ability to swim and swarm1-3. These virulence factors are 
controlled by a mechanism of  intercellular communica-
tion termed quorum sensing. Quorum sensing enables 
bacterial cells to monitor their numbers and respond by 
coordinating the expression of  genes including virulence 
genes2-4.  Some strains of  Serratia marcescens cause infec-
tions that are hard to treat. The underlying reason is their 
high resistance to many categories of  antibiotics involv-
ing fluoquinolones, aminoglycosides and β-lactams5,6. 
The high virulence and resistance of  Serratia marcescens ne-
cessitates seeking a new treatment strategy. It is supposed 
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that quorum sensing inhibition is one useful approach 
that can help in treating infections without exerting stress 
on the growth of  bacteria to avoid the evolution of  an-
tibiotic resistance. Furthermore, it can enhance the im-
mune clearance of  the pathogens7,8.
Glyceryl trinitrate (GTN) is an anti-hypertensive that has 
anti-microbial properties9,10. It could inhibit the growth 
of  Candida albicans and Pseudomonas aeruginosa planktonic 
growth10,11. Moreover, GTN exerted antibiofilm activity 
against Staphylococcus aureus, Staphylococcus epidermidis, Pseu-
domonas aeruginosa and candida albicans12. In our previous 
study, GTN was found to inhibit quorum sensing in Pseu-
domonas aeruginosa11. GTN is an FDA approved drug that 
can be used topically for anal fissures at concentrations 
that can reach 0.4%13.
This study aimed to investigate the potential anti-quorum 
sensing and anti-virulence activities of  GTN against the 
nosocomial pathogen Serratia marcescens.
Materials and methods
Media and chemicals
Tryptone soya broth, Mueller Hinton broth and Muel-
ler Hinton agar were the products of  Oxoid (Hamp-
shire, UK). Luria-Bertani (LB) broth and LB agar were 
purchased from Lab M Limited (Lancashire, United 
Kingdom).Glyceryl trinitrate was obtained from POHL-
Boskamp, Gmbh&Co., Hohenlockstedt, Germany (Stock 
solution of  1 mg/ml). Other chemicals were of  pharma-
ceutical grade.
Bacterial Strains
The Serratia marcescens isolate in this study was used in a 
previous study14. It is a clinical one obtained from an In-
tensive Care Unit patient admitted to Zagazig University 
Hospital by endotracheal aspiration. The MALDI-TOFF 
apparatus at the Clinical Pathology Department, Faculty 
of  Medicine, Zagazig University was used for identifica-
tion of  this isolate. The biosensor strain Chromobacterium 
violaceum CV026 was obtained from the Department of  
Microbiology, Faculty of  Pharmacy, Ain Shams Univer-
sity.
Determination of  Minimum Inhibitory Concentra-
tion (MIC)
The agar dilution method was used in determination 
of  the minimum inhibitory concentration of  GTN ac-
cording to the Clinical Laboratory and Standards Insti-
tute Guidelines (CLSI)15. The tested strain was incubated 
overnight in tryptone soya broth (TSB) and the suspen-
sion was diluted with Mueller-Hinton broth in order to 
prepare a suspension with a turbidity approximating that 
of  0.5McFarland Standard. The suspension was further 
diluted with sterile saline (1:10). By using a micropipette, 
a standardized inoculum (approximately 104 CFU per 
spot) was spotted on the surface of  Mueller-Hinton agar 
plates containing different GTN concentrations and con-
trol plate without GTN. The MIC of  GTN was the low-
est concentration that inhibits growth on the plate after 
incubation at 37°C for 20 h.
Effect of  GTN on bacterial growth
The effect of  sub-inhibitory concentration of  GTN on 
the growth of  the tested strain of  S. marcescens was detect-
ed according to Nalca et al.16 overnight culture from S. 
marcescens was prepared in LB broth and adjusted to 0.5 
McFarland Standard. The prepared suspension was used 
to inoculate LB broth containing 0.25 mg/ml of  GTN 
and control LB broth without GTN so that the final in-
oculum is approximately 1X106 CFU/ml. After overnight 
incubation at 37 °C, the optical densities of  both cultures 




To determine the quorum sensing inhibiting activity 
of  GTN, the biosensor strain Chromobacterium violaceum 
CV026 was used according to Choo et al17. A suspension 
of  the tested strain with OD600 of  1 was prepared from 
overnight culture. Aliquots of  100 μl of  bacterial suspen-
sion were added to the wells of  a 96-well microtiter plate 
to which aliquots of  100 μl of  LB broth with N-hexanoyl 
homoserinelactone in the presence and absence of  0.25 
mg/ml of  GTN were delivered. The plate was incubated 
at 28°C for 16 h and was dried at 60°C. The purple pig-
ment violacein was extracted by addition of  aliquots of  100 
μl of  DMSO to the wells and incubation at 30°C with 
shaking.  DMSO was used as negative control and the 




The tested strain was reported as a strong biofilm form-
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ing isolate14. To determine the ability of  GTN to inhibit 
biofilm formation, the modified method of  Abraham et 
al.18 was used. A suspension of  S. marcescens strain was 
prepared from overnight culture in tryptone soya broth 
(TSB) and its optical density was adjusted to OD600 of  
0.4 (1×108 CFU/ ml) was added. Aliquot of  10µl of  the 
suspension was added to 1 ml amounts of  fresh TSB with 
and without 0.25 mg/ml of  GTN. Aliquots of  100 µl of  
TSB with and without GTN were delivered into the wells 
of  96 wells microtiter plate and incubated at 28 °C for 24 
h. The planktonic cells were aspirated and the wells were 
washed three times with distilled water and left to dry. 
The attached cells were fixed with methanol for 20 min-
utes and stained with crystal violet (1%) for 20 minutes. 
The wells were washed and the attached dye was eluted by 
33% glacial acetic acid. The absorbance was measured at 
590 nm using Biotek Spectrofluorimeter (Biotek, USA).
The percentage of  biofilm inhibition was calculated using 
the following formula
% of  biofilm inhibition = [OD600 control- OD600 in pres-
ence of  ambroxol]/ OD600 control
Microscopic visualization of  biofilm inhibition by 
the light microscope and scanning electron micro-
scope
In order to analyze biofilm inhibition, the method of  Sa-
kar et al.19 was followed with some modification. The bio-
film of  the tested strain of  Serratia marcescens was formed 
on glass cover slips placed in polystyrene petri plates in 
the presence and absence of  0.25 mg/ml of  GTN. The 
plates were incubated for 24 h at 28°C, the cover slips 
were washed with water three times and stained with crys-
tal violet (1%) for 20 minutes. The cover slips were exam-
ined after staining under the light microscope at a 400X 
magnification. For scanning electron microscopic (SEM) 
analysis, biofilms formed on glass cover slips were fixed 
by glutaraldehyde (2.5%) for 120 minutes. After washing 
with distilled water, the cover slips were dehydrated by 
increasing concentrations of  ethanol (50%, 60%, 70%, 
80%, 90% and 100%) for 30 seconds. The samples were 
gold coated after critical-point drying and examined un-
der scanning electron microscope20.
Swimming and swarming motilities assay
The ability of  GTN to block the swimming and swarm-
ing motilities was detected according to Matsuyama et 
al.21 For swimming assay, LB agar plates containing 0.3% 
agar with and without 0.25 mg/ml GTN were prepared. 
Overnight culture of  S.marcescens in LB broth was pre-
pared and 5µl of  the suspension was inoculated into the 
center of  the plates. Swarming LB gar plates with 0.5% 
agar containing 0.25% mg/ml of  GTN and control plates 
were point inoculated with 5µl of  the prepared suspen-
sion. The plates were incubated at 28°C for 20 h. The 
zones of  swimming and swarming were measured. The 
experiment was made in triplicates and the results were 
averaged.
Prodigiosin inhibition assay
The production of  prodigiosin by S. marcescens was quan-
tified in the presence and absence of  GTN.  The tested 
strain was grown overnight in LB broth and adjusted to 
OD600 of  0.4 and inoculated in 2 ml fresh LB broth and 
incubated at 28°C for 18 h. The cells were collected by 
centrifugation at 13000 rpm for 10 minutes. To extract 
prodigiosin, acidified ethanol (4% 1M HCl in ethanol) 
was used. The absorbance was measured at 534 nm using 
Biotek Spectrofluorimeter (Biotek, USA) and the degree 
of  inhibition was determined. The experiment was made 
in triplicate and the results were averaged22.
 
Protease assay
To assay the inhibitory activity of  GTN on protease pro-
duction, the qualitative skim milk agar method was used23. 
Skim milk LB agar plates (5% skim milk) with and with-
out GTN (0.25 mg/ml) were prepared. The plates were 
surface inoculated, each with 5 µl of  overnight culture of  
S. marcescens in LB broth and incubated at 28°C for 20h. 
The diameter of  the clear zones surrounding the growth 
were measured.
Statistical analysis
The inhibitory activities of  GTN on quorum sensing and 
virulence factors of  Serratia marcescens were compared by t 
test, Graph Pad Prism 5. P values <0.05 were considered 
statistically significant.
Results
Determination of  MIC
Glyceryl trinitrate could not inhibit the growth of  Serra-
tia marcescens isolate at 0.5 mg/ml which is the maximum 
available concentration (stock solution of  GTN is of  
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concentration of  1 mg/ml), so MIC is equal to or higher 
than 1 mg/ml. the concentration selected to test the an-
ti-quorum sensing and anti-virulence activities of  GTN is 
0.25 mg/ml which is equivalent to ¼  MIC or less.
Determination of  the effect of  GTN on bacterial 
growth
To determine the effect of  GTN on growth, the optical 
densities of  the bacterial suspension at 600 nm following 
overnight incubation in LB broth were measured in the 
presence or absence of  GTN. No statistically significant 
difference was found between the turbidities of  the bac-
terial suspension with or without GTN indicating the lack 
of  the effect of  GTN on growth (Fig. 1).
Assessment of  biofilm inhibition
The biofilm formation was quantified to show the ability 
of  GTN to interfere with biofilm production. GTN at 
0.25 mg/ml produced statistically significant reduction in 
biofilm biomass (p<0.05). The percentage of  biofilm in-
hibition reached 87.83% (Fig. 2). 
 
Figure 1. Effect of GTN on growth of Serratia marcescens. No statistically significant difference  
between OD600 of the GTN treated and untreated cultures after overnight incubation in LB broth.  
 
Figure 2. Biofilm inhibition of S. marcescens by GTN.*, significant P< 0.05.  
Figure 1. Effect of GTN on growth of tia marcescens. No statistically sig ificant difference  
between OD600 of the GTN treated and unt  cultures after overnight incubation in LB broth.  
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To further explore the biofilm inhibiting activity of  GTN, 
light microscopic examination of  biofilms formed on 
glass cover slips in the presence and absence of  GTN 
was performed. In the presence of  GTN, both the thick-
ness and surface coverage were markedly decreased (Fig. 
3). Furthermore, the SEM images clearly illustrated the 
biofilm inhibiting activity of  GTN. In GTN treated sam-
ple, very few scattered cells were observed as compared 
to the untreated sample that showed the complex biofilm 
structure with aggregated cells.
 
Figure 3. Microscopic analysis of biofilm inhibition by GTN (a) SEM images   
and (b)  Light microscopic images of GTN treated and untreated biofilms. 
Inhibition of  violacein production
To prove the quorum sensing inhibition by GTN, the pro-
duction of  violacein pigment in the biosensor strain Chro-
mobacterium violaceum CV026 that is controlled by quorum 
sensing mechanism was monitored. GTN significantly 
diminished violacein production (67.01%). This confirms 
that GTN is a quorum sensing inhibitor (Fig. 4).
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Figure 4. Inhibition of violacein pigment of Chromobacterium  
violaceum CV026 by GTN. *, significant P< 0.05.   
Prodigiosin inhibition assay
Prodigiosin is another quorum-sensing controlled pig-
ment that is produced by S. marcescens. GTN showed a 
significant ability to inhibit prodigiosin production. The 
inhibition percentage achieved was 82.67% (Fig 5).
Inhibition of  Protease Production
 
Figure 5. Inhibition of prodigiosin pigment of Serratia  
marcescens by GTN. *, significant P< 0.05.  
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The skim milk agar method was used for the qualitative 
assay of  protease inhibition. GTN could interfere with 
protease production as shown by decreasing the clear 
zone of  proteolysis (Fig. 6).
Inhibition of  swimming and swarming
 
Figure 6. Inhibition of protease production by the skim milk agar method. 
Swimming and swarming motility are important for ad-
hesion and biofilm formation. In the presence of  GTN, 
swimming motility was reduced by 36.72%, while swarm-




Figure 7. Inhibition of swimming motility by GTN. *, significant P< 0.05.  
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Figure 8. Inhibition of swarming motility by GTN. *, significant P< 0.05.  
Serratia marcescens is a nosocomial bacterium that is con-
sidered the seventh most common pathogen that causes 
nosocomial pneumonia and the tenth most common one 
that is responsible for hospital acquired blood stream in-
fections24.
This study was performed to detect the possible quorum-
sensing mediated virulence factors  inhibition by  sub-in-
hibitory  concentration  of   glyceryl  trinitrate in  Serratia 
marcescens. 
The underlying reason for targeting quorum sensing is to 
bypass the stress on bacterial growth that leads to emer-
gence of  resistance and finding another way to treat in-
fection in the light of  the high antibiotic resistance of  
Serratia marcescens25. Quorum sensing is a key regulator of  
the pathogenicity in many bacteria. Inhibition of  quorum 
sensing may be beneficial in attenuation of  virulence and 
the treatment of  infections caused by resistant strains of  
bacteria26,27.
The tripyrrole red prodigiosin pigment is synthesized 
under the control of  quorum sensing in  S.  marcescens21. 
GTN  caused  remarkable  reduction  in  prodigiosin  pig-
ment.  Protease  is involved in the pathogenicity of  S. 
marcescens. GTN reduced the production of  protease28.
In this study, GTN showed high ability to inhibit biofilm. 
Biofilms render the infection difficult to treat due to the 
high resistance to antibiotics and immunity of  the host29. 
The ability of  Serratia marcescens to swim and swarm affects 
adhesion and biofilm formation. As a result, interference 
with swarming could affect biofilm production30,31. GTN 
blocked swarming motility.
The inhibition of  virulence factors production of  Serratia 
marcescens may be due to interference with quorum sens-
ing. This hypothesis was proved by the ability of  GTN to 
cause significant reduction in the production of  the quo-
rum-sensing regulated violacein pigment in the biosensor 
strain C. violaceum CV026. Moreover, GTN was previous-
ly reported as a quorum sensing inhibitor in Pseudomonas 
aeruginosa PAO1 strain11.
GTN has the advantage of  FDA approval that makes 
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GTN clinical application possible. This is very import-
ant because most quorum sensing inhibitors have toxic 
effects that hinder their use in treatment. Serratia marc-
escens causes surgical wounds infections and urinary tract 
infections. GTN can be used topically in the treatment of  
surgical site infections or as a catheter lock solutions for 
catheter associated urinary tract infections32.
Conclusion
The emergence of  antibiotic resistance makes it obligato-
ry to seek for new therapeutic options for infection con-
trol. GTN may be a useful agent in this approach because 
of  its anti-quorum sensing and anti-virulence activities 
against S. marcescens. Targeting quorum sensing regulat-
ed virulence poses no growth pressure on bacteria and 
hence the resistance is much less likely to develop.
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